Skip to main content
Clinical Trials/NCT05045456
NCT05045456
Completed
Not Applicable

Investigation Clinique Observationnelle Des Performances de Diagnostic Electrocardiographique de l'Apple Watch (App ECG Version 2.0) augmentée d'un Algorithme d'Intelligence Artificielle

Cardiologs Technologies1 site in 1 country200 target enrollmentNovember 9, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Cardiologs Technologies
Enrollment
200
Locations
1
Primary Endpoint
Performance of AF detection
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This observational prospective clinical investigation will evaluate the performance on an Artificial Intelligence (AI) solution interpreting ECG (electrocardiogram) collected from an Apple Watch (AI-AW) in the detection of Atrial Fibrillation (AF)

Detailed Description

Each patient hospitalized for ablation or cardioversion and having given consent to participate in the clinical investigation will have ECG recordings by Apple Watch performed simultaneously with a 12D ECG measurement by a cardiologist before and/or after treatment, in accordance with the existing patient monitoring protocol. Similarly, patients attending a rhythmology consultation or hospitalized in the cardiology department will have simultaneous ECG recordings with an Apple Watch during the scheduled routine 12D ECG recording.

Registry
clinicaltrials.gov
Start Date
November 9, 2021
End Date
February 23, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Cardiologs Technologies
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient aged 22 or older, able and willing to participate in the study
  • Patient admitted to hospital for ablation, cardioversion or cardiac electrophysiological exploration or who comes for regular rhythmology consultations or hospitalized in cardiology department
  • Patient who has read the information note and has given his or her consent before any procedure related to the study
  • Patient affiliated to social security

Exclusion Criteria

  • Pregnant or breastfeeding women
  • Patient with a pacemaker, implantable defibrillator or cardiac resynchronisation therapy device.
  • Subject related to the investigator or any other staff member directly involved in the conduct of the study
  • Patient incapable of giving consent, minor or adult patient protected by law

Outcomes

Primary Outcomes

Performance of AF detection

Time Frame: 1 day

Performance of AF detection by an artificial intelligence (AI) solution interpreting ECG collected via Apple Watches (AI-AW), compared to physician's diagnosis from the 12 leads ECG

Secondary Outcomes

  • AW versus AI-AW(1 day)
  • AI-AW versus AI-12lead(1 day)

Study Sites (1)

Loading locations...

Similar Trials